Acurx Pharmaceuticals, Inc.

ACXP ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Apr 22, 2026 OWNERSHIP DOCUMENT
4 Apr 22, 2026 OWNERSHIP DOCUMENT
8-K Apr 16, 2026 FORM 8-K
424B5 Apr 16, 2026 424B5
S-8 Mar 12, 2026 FORM S-8
10-K Mar 12, 2026 10-K
8-K Mar 9, 2026 FORM 8-K
EFFECT Feb 11, 2026
424B3 Feb 11, 2026 424B3
CORRESP Feb 9, 2026
UPLOAD Feb 9, 2026
S-1 Feb 2, 2026 S-1
EFFECT Jan 6, 2026
CORRESP Jan 2, 2026
S-3/A Dec 30, 2025 FORM S-3/A
SCHEDULE 13G/A Nov 14, 2025
10-Q Nov 12, 2025 10-Q
424B3 Nov 10, 2025 424B3
S-1 Oct 20, 2025 FORM S-1
8-K Sep 22, 2025 FORM 8-K
8-K Sep 19, 2025 FORM 8-K
SCHEDULE 13G Aug 14, 2025
10-Q Aug 11, 2025 10-Q
DEFA14A Aug 5, 2025 DEFA14A
DEF 14A Aug 4, 2025 DEF 14A
← Newer Page 2 of 10 · 243 filings Older →